Apollo Neuroscience

Apollo Neuroscience improves your body’s resilience to stress, so you can focus, get to sleep, and stay energized.

Beckley Psytech

Beckley Psytech is dedicated to helping patients suffering from neurological and psychiatric disorders by developing a pipeline of psychedelic compounds into licensed pharmaceutical medicines.

Bexson Biomedical

Bexson Biomedical is developing new ketamine therapies for large-market and orphan indications.

COMPASS Pathways

COMPASS Pathways is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health.


Cybin is a mushroom life sciences company focused on psychedelic medicines and nutraceutical products.

Delix Therapeutics

Delix Therapeutics is the developer of small-molecule drug compounds intended to help provide treatment against mental disorders. The company is offering enantiomer compounds for neural plasticity promoting, enabling healthcare service providers to cure patients suffering from depression, anxiety, and post-traumatic stress disorders.

Diamond Theraputics

Diamond Therapeutics develops FDA-approved, psilocybin-based therapeutics that deliver patient benefits without undesired perceptual side effects.


Eleusis is dedicated to unlocking the potential of serotonin 2A receptor agonists, commonly referred to as psychedelics, by mitigating and managing psychoactivity.

Eve Health Systems

Eve Health Systems is a mental health services matching engine and practice management system, optimizing each piece of the experience for users seeking therapy.


FREQUENCY offers breathwork classes for your emotional wellbeing.


Gilgamesh is developing the next generation of central nervous system drugs inspired by psychedelic medicines.

GHP Noetic Science-Psychedelic Pharma Inc. TSXV: PSYF

GHP Noetic Science-Psychedelic Pharma Inc. is a Capital Pool Corporation (CPC) formed to assist a future qualifying transaction to access the capital markets to fund its growth and expansion.

Merlyn Mind Logo
Merlyn Mind

Merlyn Mind is building artificial intelligence that empowers society’s most important contributors.


MindMed discovers, develops, and deploys psychedelic inspired medicines to alleviate suffering and improve health.


Noetic Consciousness Inc.

Noetic Consciousness Inc. is a Capital Pool Corporation (CPC) formed to assist a future qualifying transaction to access the capital markets to fund its growth and expansion.


Numinus is an operating company at the forefront of addressing the growing prevalence of mental health issues and the desire for greater wellness.

PsyBio Therapeutics

PsyBio Therapeutics is developing biosynthetic psychoactive compounds which offer a new paradigm of treatment to reverse the course of mental health issues.


Psygen is a manufacturer of pharmaceutical-grade psychedelic drug products for clinical research and therapeutic applications.

The Psynergia Alliance

Psynergia Alliance is a Life Sciences platform that backs, builds and incubates best-in-class companies in the mental wellness space with a focus on psychedelic therapeutics.

Rythmia Life Advancement Center

Rythmia Life Advancement Center is an all-inclusive, medically licensed resort and wellness retreat in Costa Rica.

Sana Health

Sana Health is the world’s first pain and sleep management mask, aiding people around the world.


Tactogen is developing the next generation of empathogen medicines, gentler compounds within MDMA family for at-home use that can increase feelings of openness.

Terran Biosciences

Terran aims to transform the lives of patients with neurological and psychiatric disorders through our next-generation therapeutics pipeline and imaging software device.


Vessel is the in-home wellness tracker that instantly and accurately uncovers what your body really needs.


Wake is furthering the field of fungi and plant medicine with clinical immersions and functional mushroom supplements backed by science.

Our Investment Focus

The Noetic Fund focuses on finding teams with the skills, expertise, management experience, and governance structures in place to build great businesses in one or more of the following parts of the psychedelic ecosystem: 

  • New Medicines: hallucinogenic and. Non-hallucinogenic
  • Therapy: associated training and protocol for administering psychedelic medicines
  • Consumer Brands
  • Education Platforms: at all levels of medical/mental health academia
  • Holistic Health Centers
  • Technology & Infrastructure
  • Research & Development Centers
  • Manufacturing & Distribution Platforms